Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

1,278 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
High levels of Nm23 gene expression in advanced stage of thyroid carcinomas.
Zou M, Shi Y, al-Sedairy S, Farid NR. Zou M, et al. Br J Cancer. 1993 Aug;68(2):385-8. doi: 10.1038/bjc.1993.345. Br J Cancer. 1993. PMID: 8394105 Free PMC article.
Cyp24a1 Attenuation Limits Progression of BrafV600E -Induced Papillary Thyroid Cancer Cells and Sensitizes Them to BRAFV600E Inhibitor PLX4720.
Zou M, Baitei EY, BinEssa HA, Al-Mohanna FA, Parhar RS, St-Arnaud R, Kimura S, Pritchard C, Alzahrani AS, Assiri AM, Meyer BF, Shi Y. Zou M, et al. Cancer Res. 2017 Apr 15;77(8):2161-2172. doi: 10.1158/0008-5472.CAN-16-2066. Epub 2017 Feb 27. Cancer Res. 2017. PMID: 28242615 Free PMC article.
IL-12 immunotherapy of Braf(V600E)-induced papillary thyroid cancer in a mouse model.
Parhar RS, Zou M, Al-Mohanna FA, Baitei EY, Assiri AM, Meyer BF, Shi Y. Parhar RS, et al. Lab Invest. 2016 Jan;96(1):89-97. doi: 10.1038/labinvest.2015.126. Epub 2015 Oct 26. Lab Invest. 2016. PMID: 26501867
KRAS(G12D)-mediated oncogenic transformation of thyroid follicular cells requires long-term TSH stimulation and is regulated by SPRY1.
Zou M, Baitei EY, Al-Rijjal RA, Parhar RS, Al-Mohanna FA, Kimura S, Pritchard C, BinEssa H, Alanazi AA, Alzahrani AS, Akhtar M, Assiri AM, Meyer BF, Shi Y. Zou M, et al. Lab Invest. 2015 Nov;95(11):1269-77. doi: 10.1038/labinvest.2015.90. Epub 2015 Jul 6. Lab Invest. 2015. PMID: 26146959 Free PMC article.
Concomitant RAS, RET/PTC, or BRAF mutations in advanced stage of papillary thyroid carcinoma.
Zou M, Baitei EY, Alzahrani AS, BinHumaid FS, Alkhafaji D, Al-Rijjal RA, Meyer BF, Shi Y. Zou M, et al. Thyroid. 2014 Aug;24(8):1256-66. doi: 10.1089/thy.2013.0610. Epub 2014 Jun 10. Thyroid. 2014. PMID: 24798740 Free PMC article.
Increased CYP24A1 expression is associated with BRAF(V600E) mutation and advanced stages in papillary thyroid carcinoma.
Zou M, BinHumaid FS, Alzahrani AS, Baitei EY, Al-Mohanna FA, Meyer BF, Shi Y. Zou M, et al. Clin Endocrinol (Oxf). 2014 Jul;81(1):109-16. doi: 10.1111/cen.12396. Epub 2014 Jan 21. Clin Endocrinol (Oxf). 2014. PMID: 24382015
Molecular characterization of a novel p.R118C mutation in the insulin receptor gene from patients with severe insulin resistance.
Alzahrani AS, Zou M, Baitei EY, Parhar RS, Al-Kahtani N, Raef H, Almahfouz A, Amartey JK, Al-Rijjal R, Hammami R, Meyer BF, Al-Mohanna FA, Shi Y. Alzahrani AS, et al. Clin Endocrinol (Oxf). 2012 Apr;76(4):540-7. doi: 10.1111/j.1365-2265.2011.04258.x. Clin Endocrinol (Oxf). 2012. PMID: 22017372
A novel deletion of the MEN1 gene in a large family of multiple endocrine neoplasia type 1 (MEN1) with aggressive phenotype.
Raef H, Zou M, Baitei EY, Al-Rijjal RA, Kaya N, Al-Hamed M, Monies D, Abu-Dheim NN, Al-Hindi H, Al-Ghamdi MH, Meyer BF, Shi Y. Raef H, et al. Clin Endocrinol (Oxf). 2011 Dec;75(6):791-800. doi: 10.1111/j.1365-2265.2011.04134.x. Clin Endocrinol (Oxf). 2011. PMID: 21627674
Biallelic p.R2223H mutation in the thyroglobulin gene causes thyroglobulin retention and severe hypothyroidism with subsequent development of thyroid carcinoma.
Raef H, Al-Rijjal R, Al-Shehri S, Zou M, Al-Mana H, Baitei EY, Parhar RS, Al-Mohanna FA, Shi Y. Raef H, et al. J Clin Endocrinol Metab. 2010 Mar;95(3):1000-6. doi: 10.1210/jc.2009-1823. Epub 2010 Jan 20. J Clin Endocrinol Metab. 2010. PMID: 20089614
1,278 results
Jump to page